These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30588122)

  • 1. Observational studies of treatment effectiveness: worthwhile or worthless?
    Sharma M; Nazareth I; Petersen I
    Clin Epidemiol; 2019; 11():35-42. PubMed ID: 30588122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.
    Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL
    Value Health; 2012; 15(2):217-30. PubMed ID: 22433752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
    Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
    Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance and implications of comparator selection in pharmacoepidemiologic research.
    D'Arcy M; Stürmer T; Lund JL
    Curr Epidemiol Rep; 2018 Sep; 5(3):272-283. PubMed ID: 30666285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialities.
    Jongen PJ
    Mult Scler Relat Disord; 2019 Oct; 35():142-149. PubMed ID: 31394404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies of the effectiveness and safety of antivenoms.
    Williams DJ; Habib AG; Warrell DA
    Toxicon; 2018 Aug; 150():1-10. PubMed ID: 29746978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active-comparator design and new-user design in observational studies.
    Yoshida K; Solomon DH; Kim SC
    Nat Rev Rheumatol; 2015 Jul; 11(7):437-41. PubMed ID: 25800216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of different types of foot orthoses for the treatment of plantar fasciitis.
    Landorf KB; Keenan AM; Herbert RD
    J Am Podiatr Med Assoc; 2004; 94(6):542-9. PubMed ID: 15547121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some methodological points to consider when performing systematic reviews in comparative effectiveness research.
    Berlin JA; Cepeda MS
    Clin Trials; 2012 Feb; 9(1):27-34. PubMed ID: 22049086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations in the design of randomized trials to screen for type 2 diabetes.
    Echouffo-Tcheugui JB; Prorok PC
    Clin Trials; 2014 Jun; 11(3):284-291. PubMed ID: 24459176
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.